China News Service, Suzhou, May 17 (Zhong Sheng, Zhou Jianlin) In order to strengthen the cooperation between Jiangsu Province and East Asia in the field of biomedicine and health, and achieve mutual benefit, win-win and common development, on the 17th, the Ministry of Science and Technology of Jiangsu Province and the people of Suzhou The government-sponsored East Asian Biomedicine and Health Industry Cooperation and Exchange Meeting was held in Suzhou.
Xu Kunlin, member of the Standing Committee of the Jiangsu Provincial Party Committee and Secretary of the Suzhou Municipal Party Committee, stated in his speech that biomedicine is one of the strategic emerging industries and advanced manufacturing clusters that Jiangsu focuses on development.
Suzhou City has gathered nearly 3,000 biomedical companies. In 2020, the city's biomedical and health companies will achieve revenue of more than 210 billion yuan, and the manufacturing output value will be about 175 billion yuan, maintaining an annual growth rate of more than 20% for many years.
In the ranking of China's biomedical industrial parks, Suzhou Industrial Park ranks first in its industrial innovation capability and talent competitiveness.
Xu Kunlin said that at today's cooperation and exchange meeting, 27 China-Japan-Korea biomedical and health industry cooperation projects were signed and landed in Suzhou, with a total investment of 4.8 billion US dollars.
In the next step, Suzhou will use the best government services and element guarantees to accelerate the implementation of the project.
Taking this event as a new starting point, we will increase project investment, policy support, and talent introduction to promote the accelerated development of biomedicine and health industries.
At the event, Wan Li, director of the Suzhou Municipal Bureau of Industry and Information Technology, published a theme promotion titled "Brightening up industrial landmarks and building China's Pharmaceutical Valley", and Tao Xu, deputy secretary of the Party Working Committee of Taizhou Pharmaceutical High-tech Industrial Development Zone, published a theme titled "Embracing Health, Joining Hands to Create Theme promotion of "Future".
Yonezawa Shino, consul of the Japanese Consulate General in Shanghai, said in his speech that Japanese investment in China has entered a mature and transitional period, and it is increasingly important to promote cooperation between high-quality companies in the two countries.
The health industry has huge potential for development, and it is also a significant international cooperation topic in the post-epidemic era.
This year, the Japanese Consulate General in Shanghai established a dialogue and work consultation mechanism with Suzhou, hoping to further strengthen exchanges and in-depth cooperation, and provide more opportunities for enterprises to join hands in innovation and development.
Zhu Yuanshi, the commercial consul of the Consulate General of the Republic of Korea in Shanghai, said that China and South Korea have very close cooperation in the field of biomedicine, and the companies of both sides have achieved a number of results in the research and development of anti-cancer drugs.
Jiangsu Province is an area where Chinese biopharmaceutical companies gather. In the future, it will definitely play a very crucial role in the cooperation between China and South Korea in the field of biomedicine.
(Finish)